During the past decade, Caprock Cardiac Center Research Institute, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Caprock Cardiac Center Research Institute, Inc." #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Caprock Cardiac Center Research Institute, Inc." are "Cardiovascular Disease" (2 trials), "Acute Coronary Syndromes" (1 trials), "Atrial Fibrillation" (1 trials), "Heart Failure" (1 trials) and "Iron-deficiency" (1 trials). Many other conditions were trialed in "Caprock Cardiac Center Research Institute, Inc." in a lesser frequency.

Most popular intervention types in "Caprock Cardiac Center Research Institute, Inc." are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Caprock Cardiac Center Research Institute, Inc." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Caprock Cardiac Center Research Institute, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Caprock Cardiac Center Research Institute, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Caprock Cardiac Center Research Institute, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".